Fibroblast growth in the soft agar clonogenic assay for cervix cancer radiosensitivity
1998

Fibroblast Growth in Cervix Cancer Radiosensitivity Testing

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): B Stausb0l-Gr0n, H Havsteen, J Oi'ergaard

Primary Institution: Danish Cancer Society; Department of Experimental Clinical Oncology and Department of Oncology; Aarhus University Hospital, Aarhus, Denmark

Hypothesis

Tumour cell in vitro radiosensitivity measured before treatment predicts clinical outcome of the individual patients after curative radiotherapy alone.

Conclusion

The study concluded that SF2 was a significant prognostic parameter for overall survival, local control, and metastasis-free survival.

Supporting Evidence

  • SF2 was a significant prognostic parameter for overall survival, local control, and metastasis-free survival.
  • Overall SF2 ranged from 0.31 to 0.81, with a median of 0.57.
  • Previous studies support the finding that primary tumour biopsies are a source of fibroblast colonies.

Takeaway

Researchers found that the way cancer cells respond to radiation can help predict how well patients will do after treatment.

Methodology

Tumour biopsies were obtained before treatment, and cellular in vitro radiosensitivity was assessed using the modified Courtenay-Mills soft agar clonogenic assay.

Limitations

The biological explanation for the findings is still not clear-cut.

Participant Demographics

Twelve carcinomas of the uterine cervix were studied, including nine squamous cell carcinomas, two adenocarcinomas, and one adenosquamous carcinoma.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication